An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival. The findings come from a recent clinical trial.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/10/201016112859.htm
No comments:
Post a Comment